Menu

Using Virtual Reality (VR) Models for Preoperative Planning

Status

Completed

Conditions

Kidney Cancer
Renal Cell Carcinoma

Treatments

Device: Ceevra Reveal

Study type

Interventional

Funder types

Industry

Identifiers

NCT03334344
20171006

Details and patient eligibility

About

A prospective, randomized, controlled study designed to assess whether digital virtual reality (VR) models, created from existing CT scans and MRIs, provide surgeons with an improved understanding of their patients' anatomy, resulting in more efficient operations (robotic partial nephrectomy) and improved patient care.

Enrollment

92 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject is undergoing robotic partial nephrectomy being performed by participating surgeon
  • Subject is willing to be randomized between intervention and control arms

Exclusion criteria

  • Cases involving subjects who are minors, pregnant or require an authorized representative for informed consent
  • Cases in which the subject has a solitary or horseshoe kidney
  • Cases in which the subject has more than two masses in the applicable kidney
  • Cases involving a bilateral operation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

92 participants in 2 patient groups

Intervention Arm
Experimental group
Description:
Subjects whose surgeon will be viewing VR models in connection with the in addition to the source CT/MR image
Treatment:
Device: Ceevra Reveal
Control Arm
No Intervention group
Description:
Subjects whose surgeon will only be viewing CT/MR images in connection with the case

Trial contacts and locations

6

There are currently no registered sites for this trial.

Timeline

Last updated: Aug 29, 2024

Start date

Oct 24, 2017 • 7 years ago

End date

Feb 28, 2019 • 6 years ago

Results posted

View

Aug 11, 2022 • 2 years ago

Today

May 03, 2025

Sponsor of this trial

Lead Sponsor

Data sourced from clinicaltrials.gov